Moderna Therapeutics Sucks Up Another $110 Million To Make Messenger RNA Drugs

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Moderna Therapeutics doesn’t need cash to keep the doors open, like many biotech startups. It just went out and raised a ton of dough, anyway.

The Cambridge, MA-based biotech startup, which is attempting to make injectable messenger RNA molecules that trigger production of protein drugs in the body, has raised a whopping $110 million in new equity financing.

Help employers find you! Check out all the jobs and post your resume.

Back to news